Mouse × pig chimeric antibodies expressed in baculovirus retain the same properties of their parent antibodies

Biotechnology Progress

Volumn 25, Issue 2, 2009, Pages 516-523

  Jar, Ana M ^a,c   Osorio, Fernando A ^a   López, Osvaldo J ^a,b,d  

^a UNIVERSITY OF NEBRASKA LINCOLN   (United States)

^b Wolf Biotech   (United States)

^c UNIVERSIDAD DE BUENOS AIRES   (Argentina)

^d WRIGHT STATE UNIVERSITY   (United States)

Author keywords

Baculovirus; Pig chimeric antibodies; PRRSV

Indexed keywords

AUTOIMMUNE DISORDER; BACULOVIRUS; BACULOVIRUS EXPRESSION SYSTEMS; CHIMERIC ANTIBODY; CODING REGION; DOMESTIC PIGS; ECONOMIC IMPORTANCE; ECONOMIC LOSS; HEAVY AND LIGHT CHAINS; HEAVY CHAIN; INFECTIOUS DISEASE; LIGHT CHAIN; PIG CHIMERIC ANTIBODIES; PRRSV; RECOMBINANT DNA TECHNOLOGY;

DISEASE CONTROL; DNA; MONOCLONAL ANTIBODIES; NUCLEIC ACIDS; SURFACE PLASMON RESONANCE;

CLONING;

ARTERIVIRUS; PORCINE RESPIRATORY AND REPRODUCTIVE SYNDROME VIRUS; SUIDAE; SUS SCROFA DOMESTICA;

ANTIBODY; IMMUNOGLOBULIN G;

ANIMAL; ARTERIVIRUS; ARTICLE; BACULOVIRUS; EVALUATION; GENE EXPRESSION; GENETICS; IMMUNOLOGY; METABOLISM; METHODOLOGY; MOUSE; PROTEIN ENGINEERING; SWINE; VIRUS INFECTION;

ANIMALS; ANTIBODIES; BACULOVIRIDAE; GENE EXPRESSION; IMMUNOGLOBULIN G; MICE; PORCINE REPRODUCTIVE AND RESPIRATORY SYNDROME; PORCINE RESPIRATORY AND REPRODUCTIVE SYNDROME VIRUS; PROTEIN ENGINEERING; SWINE;

EID: 66149168941     PISSN: 87567938     EISSN: None     Source Type: Journal    
DOI: 10.1002/btpr.113     Document Type: Article

References (38)

1. Neumann EJ, Kliebenstein JB, Johnson CD, Mabry JW, Bush EJ, Seitzinger AH, Green AL, Zimmerman JJ. Assessment of the economic impact of porcine reproductive and respiratory syndrome on swine production in the United States. J Am Vet Med Assoc. 2005;227:385-392.
2. Goldberg TL, Lowe JF, Milburn SM, Firkins LD. Quasispecies variation of porcine reproductive and respiratory syndrome virus during natural infection. Virology. 2003;317:197-207.
3. Fang Y, Schneider P, Zhang WP, Faaberg KS, Nelson EA, Rowland RR. Diversity and evolution of a newly emerged North American Type 1 porcine arterivirus: analysis of isolates collected between 1999 and 2004. Arch Virol. 2007;152:1009-1017.
4. Osorio FA, Zuckermann F, Wills R, Meier W, Christian S, Galeota J, Doster A. PRRSV: comparison of commercial vaccines in their ability to induce protection against current PRRSV strains of high virulence. Allen D Leman Swine Conf. 1998;25:176-182.
5. Pirzadeh B, Dea S. Immune response in pigs vaccinated with plasmid DNA encoding ORF5 of porcine reproductive and respiratory syndrome virus. J Gen Virol. 1998;79:989-999.
6. Osorio FA, Galeota JA, Nelson E, Brodersen B, Doster A, Wills R, Zuckermann F, Laegrid WW. Passive transfer of virus-specific antibodies confers protection against reproductive failure induced by a virulent strain of porcine reproductive and respiratory syndrome virus and establishes sterilizing immunity. Virology. 2002;302:9-20.
7. Lopez OJ, Oliveira MF, Garcia EA, Kwon BJ, Doster A, Osorio FA. Protection against porcine reproductive and respiratory syndrome virus (PRRSV) infection through passive transfer of PRRSV-neutralizing antibodies is dose dependent. Clin Vacc Immunol. 2007;14:269-275.
8. Davies T. Magic bullets. Nature. 1981;289:12-13.
9. Kolata G. "The" magic in magic bullets. Science. 1983;222:310-312.
10. Marwick C. Monoclonal antibody to treat lymphoma. JAMA. 1997;278:616-618.
11. Nissim A, Chernajovsky Y. Historical development of monoclonal antibody therapeutics. Handb Exp Pharmacol. 2008;181:3-18.
12. Subramanian KN, Weisman LE, Rhodes T, Ariagno R, Sánchez PJ, Steichen J, Givner LB, Jennings TL, Top FH Jr, Carlin D, Connor E. Safety, tolerance and pharmacokinetics of a humanized monoclonal antibody to respiratory syncytial virus in premature infants and infants with bronchopulmonary dysplasia. MEDI-493 Study Group. Pediatr Infect Dis J. 1998;2:110-115.
13. Kacskovics Y, Sun J, Butler JE. Five putative subclasses of swine IgG identified from the cDNA sequences of a single animal. J Immunol. 1994;153:3565-3573.
14. Lammers BM, Beaman KD, Kim Y. B. Sequence analysis of porcine immunoglobulin light chain cDNAs. Mol Immunol. 1991;28:877-880.
15. Sambrook J, Fritsch EF, Maniatis T. Molecular Cloning. A Laboratory Manual. Plainview, NY: Cold Spring Harbor Laboratory Press; 1989.
16. Yang L, Frey ML, Yoon, K-J, Zimmerman JJ, Platt KB. Categorization of North American porcine reproductive and respiratory syndrome viruses: epitopic profiles of the N, M, GP5 and GP3 proteins and susceptibility to neutralization. Arch Virol. 2000;145:1599-1619.
17. Bernard O, Hozumi N, Tonegawa S. Sequences of mouse immunoglobulin light chain genes before and after somatic changes. Cell. 1978;15:1133-1144.
18. Tonegawa S, Maxam AM, Tizard R, Bernard O, Golbert W. Sequence of a mouse germ-line gene for a variable region of an immunoglobulin light chain. Proc Natl Acad Sci USA. 1978;75:1485-1489.
19. Selsing E, Miller J, Wilson R, Storb U. Evolution of mouse immunoglobulin λ genes. Proc Natl Acad Sci USA. 1982;79:4681-4685.
20. Harlow E, Lane D. Antibodies. A Laboratory Manual. Woodbury, NY: Cold Spring Harbor Laboratory Press; 1988.
21. Ostrowski M, Galeota JA, Jar AM, Platt KB, Osorio FA, Lopez OJ. Identification of neutralizing and nonneutralizing epitopes in the porcine reproductive and respiratory syndrome virus GP5 ectodomain. J Virol. 2002;76:4241-4250.
22. Magar R, Larochelle R, Dea S, Gagnon CA, Nelson EA, Christopher-Hennings J, Benfield DA. Antigenic comparison of Canadian and US isolates of porcine reproductive and respiratory syndrome virus using monoclonal antibodies to the nucleocapsid protein. Can J Vet Res. 1995;59:232-234.
23. Butler JE, Sun J, Wertz N, Sinkora M Antibody repertoire development in swine. Dev Comp Immunol. 2006;30:199-221.
24. Nimmerjahn F, Ravetch JV. Divergent immunoglobulin G subclass activity through selective Fc receptor binding. Science. 2005;310:151-152.
25. Bernatowska-Matuszkiewicz E, Pac M, Pum M, Liszka K, Leibl H, Eibl M Ig subclasses and antibody response to pneumococcal capsular polysaccharides in children with severe sinopulmonary infections and asthma. Immunol Invest. 1991;20:173-185.
26. Capozzo AV, Periolo OH, Robiolo B, Seki C, La Torre JL, Grigera PR. Total and isotype humoral responses in cattle vaccinated with foot and mouth disease virus (FMDV) immunogen produced either in bovine tongue tissue or in BHK-21 cell suspension cultures. Vaccine. 1997;15:624-630.
27. Brüggemann M, Williams GT, Bindon CI, Clark MR, Walker MR, Jefferis R, Waldmann H, Neuberger M. Comparison of the effector functions of human immunoglobulins using a matched set of chimeric antibodies. J Exp Med. 1987;166:1351-1361.
28. Dangl JL, Wensel TG, Morrison SL, Stryer L, Herzenberg LA, Oi VT. Segmental flexibility and complement fixation of genetically engineered chimeric human, rabbit and mouse antibodies. EMBO J. 1988;7:1989-1994.
29. Bianchi A, Butler JE, Hoorfar J, Howard C, Lind P. Workshop summary: immunoglobulins and Fc receptors. Vet Immunol Immunopathol. 1996;54:25-31.
30. Crawley A, Wilkie BN. Porcine Ig isotypes: function and molecular characteristics. Vaccine. 2003;21:2911-2922.
31. Plagemann PG, Rowland RR, Faaberg KS. The primary neutralization epitope of porcine respiratory and reproductive syndrome virus strain VR-2332 is located in the middle of the GP5 ectodomain. Arch Virol. 2002;147:2327-2347.
32. Cancel-Tirado SM, Evans RB, Yoon K-J. Monoclonal antibody analysis of porcine reproductive and respiratory syndrome virus epitopes associated with antibody-dependent enhancement and neutralization of virus infection. Vet Immunol Immunopathol. 2004;102:249-262.
33. Ansari IH, Kwon B, Osorio FA, Pattnaik AK. Influence of Nlinked glycosylation of porcine reproductive and respiratory syndrome virus GP5 on virus infectivity, antigenicity, and ability to induce neutralizing antibodies. J. Virol. 2006;80:3994-4004.
34. Burton DR, Stanfield RL, Wilson IA. Antibody vs. HIV in a clash of evolutionary titans. Proc Natl Acad Sci USA. 2005;102:14943-14948.
35. Sun J, Hayward C, Shinde R, Christenson R, Ford SP, Butler JE. Antibody repertoire development in fetal and neonatal piglets. I. Four VH genes account for 80 percent of VH usage during 84 days of fetal life. J Immunol. 1998;161:5070-5078.
36. Pérez C, Wylie D, López O. Variable kappa gene usage in swine antibodies. Medicina (Buenos Aires). 2003;63:299-302.
37. Li F, Aitken, R. Cloning of porcine scFv antibodies by phage display and expression in Escherichia coli. Vet Immunol Immunopathol. 2004;97:39-51.
38. Giritch A, Marillonnet S, Engler C, van Eldik G, Botterman J, Klimyuk V, Gleba Y. Rapid high-yield expression of full-size IgG antibodies in plants coinfected with noncompeting viral vectors. Proc Natl Acad Sci USA. 2006;40:14701-14706.